 |
PDBsum entry 4u7l
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
4u7l
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
427:1934-1948
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
LRIG1 extracellular domain: structure and function analysis.
|
|
Y.Xu,
P.Soo,
F.Walker,
H.H.Zhang,
N.Redpath,
C.W.Tan,
N.A.Nicola,
T.E.Adams,
T.P.Garrett,
J.G.Zhang,
A.W.Burgess.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We have expressed and purified three soluble fragments of the human LRIG1-ECD
(extracellular domain): the LRIG1-LRR (leucine-rich repeat) domain, the
LRIG1-3Ig (immunoglobulin-like) domain, and the LRIG1-LRR-1Ig fragment using
baculovirus vectors in insect cells. The two LRIG1 domains crystallised so that
we have been able to determine the three-dimensional structures at 2.3Å
resolution. We developed a three-dimensional structure for the LRIG1-ECD using
homology modelling based on the LINGO-1 structure. The LRIG1-LRR domain and the
LRIG1-LRR-1Ig fragment are monomers in solution, whereas the LRIG1-3Ig domain
appears to be dimeric. We could not detect any binding of the LRIG1 domains or
the LRIG1-LRR-1Ig fragment to the EGF receptor (EGFR), either in solution using
biosensor analysis or when the EGFR was expressed on the cell surface. The
FLAG-tagged LRIG1-LRR-1Ig fragment binds weakly to colon cancer cells regardless
of the presence of EGFRs. Similarly, neither the soluble LRIG1-LRR nor the
LRIG1-3Ig domains nor the full-length LRIG1 co-expressed in HEK293 cells
inhibited ligand-stimulated activation of cell-surface EGFR.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |